• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲药品管理局关于非甾体抗炎药用于治疗新冠肺炎的建议。

EMA advice on the use of NSAIDs for Covid-19.

出版信息

Drug Ther Bull. 2020 May;58(5):69. doi: 10.1136/dtb.2020.000021. Epub 2020 Mar 31.

DOI:10.1136/dtb.2020.000021
PMID:32234728
Abstract

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.

摘要

每月,《药物与治疗通报》都会浏览有关治疗、疾病管理及其他医疗保健主题的信息来源,筛选关键内容以引起读者关注,并帮助他们与时俱进。为此,我们会对相关信息进行简洁且结合背景的总结。

相似文献

1
EMA advice on the use of NSAIDs for Covid-19.欧洲药品管理局关于非甾体抗炎药用于治疗新冠肺炎的建议。
Drug Ther Bull. 2020 May;58(5):69. doi: 10.1136/dtb.2020.000021. Epub 2020 Mar 31.
2
EMA advice on renin-angiotensin system medicines during covid-19 pandemic.欧洲药品管理局关于2019冠状病毒病大流行期间肾素-血管紧张素系统药物的建议。
Drug Ther Bull. 2020 Jun;58(6):85. doi: 10.1136/dtb.2020.000026. Epub 2020 Apr 15.
3
Misguided drug advice for COVID-19.针对新冠病毒病的错误用药建议。
Science. 2020 Mar 27;367(6485):1434. doi: 10.1126/science.abb8034. Epub 2020 Mar 20.
4
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?COVID-19 和避免使用布洛芬。证据有多好?
Am J Ther. 2020 Jul/Aug;27(4):e400-e402. doi: 10.1097/MJT.0000000000001196.
5
Is the risk of ibuprofen or other non-steroidal anti-inflammatory drugs increased in COVID-19?新冠病毒感染时布洛芬或其他非甾体抗炎药的风险会增加吗?
J Paediatr Child Health. 2020 Oct;56(10):1645-1646. doi: 10.1111/jpc.15159. Epub 2020 Aug 30.
6
Covid-19-The real role of NSAIDs in Italy.新冠疫情——非甾体抗炎药在意大利的实际作用
J Orthop Surg Res. 2020 May 4;15(1):165. doi: 10.1186/s13018-020-01682-x.
7
2019 Novel Coronavirus-Important Information for Clinicians.2019新型冠状病毒——临床医生重要信息
JAMA. 2020 Mar 17;323(11):1039-1040. doi: 10.1001/jama.2020.1490.
8
Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence.非甾体抗炎药在 COVID-19 管理中的应用:当前证据的系统评价。
Int J Clin Pract. 2020 Sep;74(9):e13557. doi: 10.1111/ijcp.13557. Epub 2020 Jun 14.
9
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.布洛芬对新型冠状病毒病 19(COVID-19)、ACE2 和免疫系统的潜在药理学影响和安全性的叙述性综述:期望与现实的二分法。
Inflammopharmacology. 2020 Oct;28(5):1141-1152. doi: 10.1007/s10787-020-00745-z. Epub 2020 Aug 14.
10
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?病毒感染患者(包括新冠病毒)中使用 NSAIDs:是受害者还是肇事者?
Pharmacol Res. 2020 Jul;157:104849. doi: 10.1016/j.phrs.2020.104849. Epub 2020 Apr 29.

引用本文的文献

1
[Events attributable to Vaxzevria vaccine in pregnant women from a first-level hospital in Puebla].[普埃布拉一级医院孕妇中与Vaxzevria疫苗相关的事件]
Rev Med Inst Mex Seguro Soc. 2024 Sep 2;62(5):1-6. doi: 10.5281/zenodo.12667969.
2
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.新型冠状病毒肺炎(COVID-19)治疗方法:旧药新用的临床应用及基于靶点的药物发现的未来策略
Genes Dis. 2023 Jul;10(4):1402-1428. doi: 10.1016/j.gendis.2022.12.019. Epub 2023 Apr 7.
3
Commentary on COVID-19-induced liver injury in various age and risk groups.
关于不同年龄和风险群体中新冠病毒感染所致肝损伤的评论
World J Virol. 2023 Jan 25;12(1):44-52. doi: 10.5501/wjv.v12.i1.44.
4
Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and relationship with mortality among United States Veterans after testing positive for COVID-19.慢性使用非甾体抗炎药(NSAIDs)或对乙酰氨基酚与 COVID-19 检测呈阳性后的美国退伍军人的死亡率之间的关系。
PLoS One. 2022 May 5;17(5):e0267462. doi: 10.1371/journal.pone.0267462. eCollection 2022.
5
A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.综述:新型冠状病毒肺炎患者肌肉骨骼疼痛的表现、机制及治疗
Front Pain Res (Lausanne). 2022 Mar 10;3:826160. doi: 10.3389/fpain.2022.826160. eCollection 2022.
6
Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy.因新冠病毒病住院患者的肝损伤:治疗的可能作用
Vaccines (Basel). 2022 Jan 26;10(2):192. doi: 10.3390/vaccines10020192.
7
Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.SARS-COV-2 的炎症、免疫及潜在靶点治疗:全尺度分析综述。
Food Chem Toxicol. 2021 Apr;150:112087. doi: 10.1016/j.fct.2021.112087. Epub 2021 Feb 25.
8
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications.抗氧化和抗炎疗法在预防严重SARS-CoV-2并发症中的潜在作用。
Antioxidants (Basel). 2021 Feb 10;10(2):272. doi: 10.3390/antiox10020272.
9
Emerging treatment strategies for COVID-19 infection.针对 COVID-19 感染的新兴治疗策略。
Clin Exp Med. 2021 May;21(2):167-179. doi: 10.1007/s10238-020-00671-y. Epub 2020 Oct 30.
10
Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.COVID-19 相关疾病流行期间系统性风湿病患者的管理建议。
Korean J Intern Med. 2020 Nov;35(6):1317-1332. doi: 10.3904/kjim.2020.417. Epub 2020 Sep 15.